Desq Long
Sign in

Company

Legend Biotech Corp

LEGN · CIK 0001801198

SEC FORM 4
$258,920.20

Legend Biotech Corp (LEGN)

Sale of 27,370 shares at $9.46 per share.

Reporting Person Sanders Corazon (Corsee) D. · Transaction Code S

Traded Sep 29, 2026 · Disclosed Oct 1, 2026

Source: SEC Form 4 · 0001796536-26-000010 · filed 2026-10-01 · View filing →

SEC FORM 4
$0.00

Legend Biotech Corp (LEGN)

Acquisition (code A) of 20,986 shares at $0 per share.

Reporting Person Sanders Corazon (Corsee) D. · Transaction Code A

Traded Sep 24, 2026 · Disclosed Sep 28, 2026

Source: SEC Form 4 · 0001796536-26-000009 · filed 2026-09-28 · View filing →

SEC FORM 4
$0.00

Legend Biotech Corp (LEGN)

Acquisition (code A) of 20,986 shares at $0 per share.

Reporting Person Heyman Tomas J. · Transaction Code A

Traded Sep 24, 2026 · Disclosed Sep 28, 2026

Source: SEC Form 4 · 0001814673-26-000005 · filed 2026-09-28 · View filing →

SEC FORM 4
$0.00

Legend Biotech Corp (LEGN)

Acquisition (code A) of 28,330 shares at $0 per share.

Reporting Person Ji Darren Xiaohui · Transaction Code A

Traded Sep 24, 2026 · Disclosed Sep 28, 2026

Source: SEC Form 4 · 0001974687-26-000006 · filed 2026-09-28 · View filing →

SEC FORM 4
$0.00

Legend Biotech Corp (LEGN)

Acquisition (code A) of 20,986 shares at $0 per share.

Reporting Person Casey Patrick John · Transaction Code A

Traded Sep 24, 2026 · Disclosed Sep 28, 2026

Source: SEC Form 4 · 0002068365-26-000009 · filed 2026-09-28 · View filing →

SEC FORM 4
$0.00

Legend Biotech Corp (LEGN)

Acquisition (code A) of 28,330 shares at $0 per share.

Reporting Person Salovey Peter · Transaction Code A

Traded Sep 24, 2026 · Disclosed Sep 28, 2026

Source: SEC Form 4 · 0002088468-26-000006 · filed 2026-09-28 · View filing →

SEC FORM 4
$0.00

Legend Biotech Corp (LEGN)

Acquisition (code A) of 20,986 shares at $0 per share.

Reporting Person Mao Li · Transaction Code A

Traded Sep 24, 2026 · Disclosed Sep 28, 2026

Source: SEC Form 4 · 0002106809-26-000005 · filed 2026-09-28 · View filing →

SEC FORM 4
$0.00

Legend Biotech Corp (LEGN)

Acquisition (code A) of 19,676 shares at $0 per share.

Reporting Person Santos Carlos E · Officer Title Chief Financial Officer · Transaction Code A

Traded Sep 21, 2026 · Disclosed Sep 23, 2026

Source: SEC Form 4 · 0002097065-26-000005 · filed 2026-09-23 · View filing →

SEC FORM 4
$49,630.20

Legend Biotech Corp (LEGN)

Sale of 5,430 shares at $9.14 per share.

Reporting Person Santos Carlos E · Officer Title Chief Financial Officer · Transaction Code S

Traded Sep 21, 2026 · Disclosed Sep 23, 2026

Source: SEC Form 4 · 0002097065-26-000005 · filed 2026-09-23 · View filing →

SEC FORM 4
$0.00

Legend Biotech Corp (LEGN)

Acquisition (code A) of 1,131,860 shares at $0 per share.

Reporting Person Zhang Ingrid · Officer Title Chief Executive Officer · Transaction Code A

Traded Sep 15, 2026 · Disclosed Sep 16, 2026

Source: SEC Form 4 · 0001964342-26-000004 · filed 2026-09-16 · View filing →

SEC FORM 4
$0.00

Legend Biotech Corp (LEGN)

Acquisition (code A) of 4,908 shares at $0 per share.

Reporting Person BASH ALAN · Officer Title Interim CEO · Transaction Code A

Traded Aug 14, 2026 · Disclosed Aug 18, 2026

Source: SEC Form 4 · 0001908421-26-000005 · filed 2026-08-18 · View filing →